These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34658019)

  • 1. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges.
    Tawana K; Brown AL; Churpek JE
    Br J Haematol; 2022 Mar; 196(6):1293-1310. PubMed ID: 34658019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
    West AH; Godley LA; Churpek JE
    Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
    Tawana K; Drazer MW; Churpek JE
    Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial myelodysplasia and acute myeloid leukaemia--a review.
    Owen C; Barnett M; Fitzgibbon J
    Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Banaszak LG; Cabral PL; Smith-Simmer K; Hassan A; Brunner M; Fallon M; Shoger K; Lovrien L; Golner D; Zurbriggen L; Mattison R; Gahvari Z; Hall A; Nadiminti K; Reinig E; Churpek JE
    JCO Precis Oncol; 2024 Jun; 8():e2300518. PubMed ID: 38848520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in acute leukemia and myelodysplasia.
    Carraway HE; Pollyea DA; Stein EM
    Best Pract Res Clin Haematol; 2022 Dec; 35(4):101415. PubMed ID: 36517125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
    Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in MDS/AML predisposition disorders.
    Godley LA
    Curr Opin Hematol; 2021 Mar; 28(2):86-93. PubMed ID: 33394724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome.
    Hughes CFM; Gallipoli P; Agarwal R
    Pathology; 2021 Apr; 53(3):328-338. PubMed ID: 33676768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.
    Iacobucci I; Mullighan CG
    Curr Opin Hematol; 2021 Mar; 28(2):101-109. PubMed ID: 33427759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic features in a patient with germline CEBPA-mutant acute myeloid leukaemia.
    Yan B; Ng C; Moshi G; Ban K; Lee PL; Seah E; Chiu L; Koay ES; Liu TC; Ng CH; Chng WJ; Koh LP
    J Clin Pathol; 2016 Jul; 69(7):652-4. PubMed ID: 27010436
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
    Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
    Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
    Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
    Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
    Klco JM; Mullighan CG
    Nat Rev Cancer; 2021 Feb; 21(2):122-137. PubMed ID: 33328584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predisposition and progression of myelodysplastic syndromes].
    Makishima H
    Rinsho Ketsueki; 2021; 62(4):278-288. PubMed ID: 33967153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
    Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
    Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer spectrum and outcomes in the Mendelian short telomere syndromes.
    Schratz KE; Haley L; Danoff SK; Blackford AL; DeZern AE; Gocke CD; Duffield AS; Armanios M
    Blood; 2020 May; 135(22):1946-1956. PubMed ID: 32076714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
    Czuchlewski DR; Peterson LC
    Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.